Alfred Sandrock insider trades

Open-market stock purchases and sales by Alfred Sandrock, President and CEO at Voyager Therapeutics, Inc, from SEC Form 4 filings since Sep 16, 2013.

Recent trades

DateStockTradeValue
Apr 2, 2026VYGR Voyager Therapeutics, IncSold$44.5K
Feb 24, 2026VYGR Voyager Therapeutics, IncSold$53.8K
Feb 18, 2026VYGR Voyager Therapeutics, IncSold$40K
Feb 10, 2026VYGR Voyager Therapeutics, IncSold$46.1K
Feb 6, 2026VYGR Voyager Therapeutics, IncBought (not open market)—
Feb 6, 2026VYGR Voyager Therapeutics, IncBought (not open market)—

Companies traded

  • VYGR Voyager Therapeutics, Inc: 10 sales, last Apr 2, 2026
  • BIIB Biogen Inc: 32 sales, last Jun 7, 2021
  • NBIX Neurocrine Biosciences Inc: other filings, last May 22, 2019

Get free alerts when Alfred Sandrock files a new trade →